Device Trial Radar · NCT06217081
3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
78
Actual
Start
Oct 28, 2024
Primary completion
Jun 24, 2025
Study completion Jun 24, 2025
Sponsor
- Lead sponsor
- Solventum US LLCNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- United States Department of Defense; The University of Texas Health Science Center at San Antonio; 3M
- First posted
- Jan 22, 2024
Design
- Study type
- Interventional
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to generate safety and performance data for 3M™ Topical Tissue Adhesive. Enrolled subjects with qualifying trauma lacerations or surgical incisions will be randomized to receive 3M™ Topical Tissue Adhesive or Histoacryl® Blue Topical Skin Adhesive with follow-up visits at 10 days and 30 days after application of tissue adhesive.
Conditions
- Trauma-related Wound
- Surgical Incision
- Surgical Wound
- Laceration
Interventions
3M Topical Tissue AdhesiveDevice
Application of investigational topical tissue adhesive to trauma laceration or surgical incision.
Histoacryl® Blue Topical Skin AdhesiveDevice
Application of control topical tissue adhesive to trauma laceration or surgical incision.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Apposition of Skin EdgesTime frame: 10 days
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.